Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns

Burns

Volumn 27, Issue 6, 2001, Pages 569-575

  Aoki, Katsunori ^a   Aikawa, Naoki ^a   Sekine, Kazuhiko ^a   Yamazaki, Motoyasu ^a   Mimura, Takuya ^a   Urano, Tetsumei ^b   Takada, Akikazu ^b  

^a KEIO UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Burn; Disseminated intravascular coagulation (DIC); Fibrinolysis; Plasminogen activator inhibitor type 1 (PAI 1); Stress; Tissue type plasminogen activator (t PA)

Indexed keywords

ANTITHROMBIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; THROMBOMODULIN;

ADULT; ARTICLE; BLOOD CLOTTING; BURN; CLINICAL ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM LESION; ENZYME IMMUNOASSAY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MALE; STRESS;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BURNS; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034885376     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(01)00011-0     Document Type: Article

References (20)

1. Is there a need for antithrombin III substitution early after burn injury?
2. Early, fatal disseminated intravascular coagulation in a patient with 60 per cent burns
3. The changes of fibrinolysis in plasma and wounds in rats inflicted with deep partial thickness burns
4. The effect of burn wound size on hemostasis: A correlation of the hemostatic changes to the clinical state
5. Cytokines and plasminogen activator inhibitor-1 in post-trauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome
6. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma
7. Determination of plasminogen activator inhibitor 1 in plasma using two different anticoagulants and methods
8. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1
9. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA
10. Determination of human thrombin antithrombin III complex in plasma with an enzyme-linked immunoassay
11. Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using the substrate, H-D-Phe-Pip-Arg-p-Nitroanilide-2HCl
12. 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator induced clot lysis
13. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies
14. Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins
15. Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
16. IL-1 beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury